Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
October 20, 2010
[Molecular target drug for hypertension and cardiovascular disease]
Toshio Nishikimi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 25, 2012
[Clinical significance of BNP as a biomarker for cardiac disease--from a viewpoint of basic science and clinical aspect]
Toshio Nishikimi
Current Medicinal Chemistry
|
June 23, 2007
Adrenomedullin in the kidney-renal physiological and pathophysiological roles
Toshio Nishikimi
Biology
|
September 14, 2022
B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Toshio Nishikimi, Yasuaki Nakagawa
Journal of Pharmacological Sciences
|
January 7, 2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis
Toshio Nishikimi, Hiroaki Matsuoka
Biology
|
February 25, 2022
Cardiac Peptides-Current Physiology, Pathophysiology, Biochemistry, Molecular Biology, and Clinical Application
Toshio Nishikimi, Johji Kato
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
June 25, 2005
Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure
Toshio Nishikimi, Hiroaki Matsuoka
Heart Failure Clinics
|
November 21, 2017
Adrenomedullin as a Biomarker of Heart Failure
Toshio Nishikimi, Yasuaki Nakagawa
Journal of Cardiology
|
June 5, 2021
Potential pitfalls when interpreting plasma BNP levels in heart failure practice
Toshio Nishikimi, Yasuaki Nakagawa
Biology
|
September 14, 2022
CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System
Yasuaki Nakagawa, Toshio Nishikimi
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
October 20, 2010
[Molecular target drug for hypertension and cardiovascular disease]
Toshio Nishikimi
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 25, 2012
[Clinical significance of BNP as a biomarker for cardiac disease--from a viewpoint of basic science and clinical aspect]
Toshio Nishikimi
Current Medicinal Chemistry
|
June 23, 2007
Adrenomedullin in the kidney-renal physiological and pathophysiological roles
Toshio Nishikimi
Biology
|
September 14, 2022
B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Toshio Nishikimi, Yasuaki Nakagawa
Journal of Pharmacological Sciences
|
January 7, 2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis
Toshio Nishikimi, Hiroaki Matsuoka
Biology
|
February 25, 2022
Cardiac Peptides-Current Physiology, Pathophysiology, Biochemistry, Molecular Biology, and Clinical Application
Toshio Nishikimi, Johji Kato
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|
June 25, 2005
Cardiac adrenomedullin: its role in cardiac hypertrophy and heart failure
Toshio Nishikimi, Hiroaki Matsuoka
Heart Failure Clinics
|
November 21, 2017
Adrenomedullin as a Biomarker of Heart Failure
Toshio Nishikimi, Yasuaki Nakagawa
Journal of Cardiology
|
June 5, 2021
Potential pitfalls when interpreting plasma BNP levels in heart failure practice
Toshio Nishikimi, Yasuaki Nakagawa
Biology
|
September 14, 2022
CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System
Yasuaki Nakagawa, Toshio Nishikimi
Page
of 10